Intervention Review

Trifluoperazine versus low-potency first-generation antipsychotic drugs for schizophrenia

  1. Magdolna Tardy1,*,
  2. Markus Dold1,
  3. Rolf R Engel2,
  4. Stefan Leucht3

Editorial Group: Cochrane Schizophrenia Group

Published Online: 8 JUL 2014

Assessed as up-to-date: 17 NOV 2010

DOI: 10.1002/14651858.CD009396.pub2


How to Cite

Tardy M, Dold M, Engel RR, Leucht S. Trifluoperazine versus low-potency first-generation antipsychotic drugs for schizophrenia. Cochrane Database of Systematic Reviews 2014, Issue 7. Art. No.: CD009396. DOI: 10.1002/14651858.CD009396.pub2.

Author Information

  1. 1

    Technische Universität München Klinikum rechts der Isar, Klinik und Poliklinik für Psychiatrie und Psychotherapie, München, Germany

  2. 2

    Ludwig-Maximilians-University Munich, Psychiatric Hospital, Muenchen, Germany

  3. 3

    Technische Universität München, Department of Psychiatry and Psychotherapy, München, Germany

*Magdolna Tardy, Klinik und Poliklinik für Psychiatrie und Psychotherapie, Technische Universität München Klinikum rechts der Isar, Möhlstr. 26, München, 81675, Germany. magdolnatardy@yahoo.de. tmaggie78@googlemail.com.

Publication History

  1. Publication Status: New
  2. Published Online: 8 JUL 2014

SEARCH

  1. Current Version

    Trifluoperazine versus low-potency first-generation antipsychotic drugs for schizophrenia

    Magdolna Tardy, Markus Dold, Rolf R Engel and Stefan Leucht

    Article first published online: 8 JUL 2014 | DOI: 10.1002/14651858.CD009396.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Trifluoperazine versus low-potency first generation antipsychotic drugs for schizophrenia

    Magdolna Tardy, Stefan Leucht, Andrey Potapov, Rolf Engel, Markus Dold and Werner Kissling

    Article first published online: 5 OCT 2011 | DOI: 10.1002/14651858.CD009396